Bio-Rad Laboratories, Inc. (NYSE:BIO)

CAPS Rating: 5 out of 5

The Company manufactures and supplies the life science research, healthcare, analytical chemistry, and other markets with products and systems used to separate chemical and biological materials, and to identify analyze and purify their components.

Recs

0
Player Avatar Estebancruise (98.02) Submitted: 11/2/2008 12:09:50 PM : Outperform Start Price: $85.03 BIO Score: -20.66

Great management with well balanced healthcare portfolio with a position in tools and diagnostics.

Featured Broker Partners


Advertisement